Joint R&D with the Wangshuhe Institute of Biomedical Engineering Technology.

Wangshuhe Biomedicine (Wuhan) Co., Ltd. has built an interdisciplinary R&D team of more than 100 members, including Russian academicians, professors and associate professors, project R&D staff, project management and drug-registration personnel, engineering technicians, and master's and doctoral researchers.

The team specializes in nano-drugs and nano-delivery systems, supported by a leading domestic nano-biopharmaceutical technology platform and outstanding research conditions.

Located in Optics Valley Bio-City, a national-level biotech industrial base in Wuhan, the site comprises a 3,000 m² laboratory and a nearly 10,000 m² pilot plant built to GMP standards, equipped with more than 100 large-scale instruments for preparing and characterizing nano-drugs and nano-intermediates, worth over RMB 10 million in total. It provides strong R&D capability and supports both pilot-scale and large-scale production of nano-drugs and nano-carriers.